| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 5.04e-05 | 118 | 162 | 7 | GO:0003774 | |
| GeneOntologyMolecularFunction | ATPase-coupled inorganic anion transmembrane transporter activity | 6.03e-05 | 10 | 162 | 3 | GO:0043225 | |
| GeneOntologyMolecularFunction | ABC-type xenobiotic transporter activity | 2.22e-04 | 15 | 162 | 3 | GO:0008559 | |
| GeneOntologyBiologicalProcess | cytoskeleton-dependent intracellular transport | LCA5 IFT140 MYO5A DYNC2H1 CCDC186 STK11 AP3B2 WDR35 KIF5B KIF13A | 1.19e-05 | 225 | 162 | 10 | GO:0030705 |
| GeneOntologyBiologicalProcess | vesicle cytoskeletal trafficking | 1.44e-05 | 67 | 162 | 6 | GO:0099518 | |
| GeneOntologyBiologicalProcess | transport along microtubule | 2.65e-05 | 197 | 162 | 9 | GO:0010970 | |
| GeneOntologyBiologicalProcess | protein localization to cilium | 3.20e-05 | 77 | 162 | 6 | GO:0061512 | |
| GeneOntologyBiologicalProcess | microtubule-based transport | LCA5 IFT140 MYO5A DYNC2H1 STK11 AP3B2 WDR35 KIF5B KIF13A CCDC40 | 3.26e-05 | 253 | 162 | 10 | GO:0099111 |
| GeneOntologyBiologicalProcess | microtubule-based process | LCA5 IFT140 MAP7D3 GIT1 MYO5A CLIP2 DYNC2H1 HAUS5 DNAH14 FSIP2 STK11 EHHADH CEP250 AP3B2 CCDC78 WDR35 UHRF1 KIF5B CROCC KIF13A CCDC40 | 8.62e-05 | 1058 | 162 | 21 | GO:0007017 |
| Domain | ARM-type_fold | NOC2L PKP4 XPO4 ITPR1 UPF2 PIK3C2B AP3B2 UTP20 PDS5A DAAM2 CTNND2 HECTD1 UNC79 SYMPK | 1.58e-06 | 339 | 162 | 14 | IPR016024 |
| Domain | SPIN-2 | 7.48e-05 | 2 | 162 | 2 | IPR029564 | |
| Domain | - | 1.41e-04 | 222 | 162 | 9 | 1.25.10.10 | |
| Domain | Ubiquitin-rel_dom | 2.07e-04 | 184 | 162 | 8 | IPR029071 | |
| Domain | - | 3.22e-04 | 248 | 162 | 9 | 1.25.40.20 | |
| Domain | ANK | 3.52e-04 | 251 | 162 | 9 | SM00248 | |
| Domain | ANK_REPEAT | 3.72e-04 | 253 | 162 | 9 | PS50088 | |
| Domain | IQ | 3.79e-04 | 71 | 162 | 5 | PF00612 | |
| Domain | Ankyrin_rpt-contain_dom | 3.83e-04 | 254 | 162 | 9 | IPR020683 | |
| Domain | ANK_REP_REGION | 3.83e-04 | 254 | 162 | 9 | PS50297 | |
| Domain | Mib_Herc2 | 4.44e-04 | 4 | 162 | 2 | IPR010606 | |
| Domain | MIB_HERC2 | 4.44e-04 | 4 | 162 | 2 | PS51416 | |
| Domain | MIB_HERC2 | 4.44e-04 | 4 | 162 | 2 | PF06701 | |
| Domain | Ankyrin_rpt | 4.80e-04 | 262 | 162 | 9 | IPR002110 | |
| Domain | ARM-like | 5.96e-04 | 270 | 162 | 9 | IPR011989 | |
| Domain | IQ | 6.95e-04 | 81 | 162 | 5 | SM00015 | |
| Domain | ATP-guanido_PTrfase | 7.35e-04 | 5 | 162 | 2 | IPR000749 | |
| Domain | SPIN/Ssty | 7.35e-04 | 5 | 162 | 2 | IPR003671 | |
| Domain | Spin-Ssty | 7.35e-04 | 5 | 162 | 2 | PF02513 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | CAD EIF4H MYO5A NOC2L MARS1 PKP4 TUT7 PHB2 KRR1 PRPF8 POLR3A SMTN RAD50 PDE12 UPF2 MYH14 PLEKHG3 SGPL1 MRPS15 SMARCA1 ANKIB1 UTP20 PDS5A KIF5B HERC2 GOLGA4 TP53BP2 | 2.37e-10 | 1353 | 164 | 27 | 29467282 |
| Pubmed | GPD2 DENND2A CAD GIT1 MYO5A CLIP2 MARS1 PKP4 PHB2 FAM98B SHROOM2 CKB DIP2A UPF2 MYH14 SRGAP3 SGPL1 AP3B2 PACS2 RIMBP2 CTNNA1 KIF5B CTNND2 CROCC PSPC1 TP53BP2 | 3.75e-09 | 1431 | 164 | 26 | 37142655 | |
| Pubmed | CAD GIT1 MYO5A CLIP2 CENPF PKP4 PHB2 EPM2AIP1 RAD50 NRXN1 SRGAP3 RIMBP2 CTNNA1 KIF5B QSER1 FRMPD3 HERC2 CTNND2 UNC79 GOLGA4 TP53BP2 | 6.23e-09 | 963 | 164 | 21 | 28671696 | |
| Pubmed | EIF4H P3H3 CCDC186 PHB2 XPO4 CKB EIF2B1 CEP250 UTP20 KIF5B HECTD1 ATP2A3 | 1.26e-08 | 285 | 164 | 12 | 32838362 | |
| Pubmed | CAD MYO5A CENPF NOC2L TUT7 KRR1 PRPF8 RAD50 CKB MYH14 UTP20 PDS5A CTNNA1 KIF5B HERC2 HECTD1 SYMPK | 1.51e-08 | 653 | 164 | 17 | 22586326 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | GPD2 CAD CENPF DYNC2H1 NOC2L MARS1 PHB2 KRR1 PRPF8 POLR3A RAD50 CKB PDE12 MYH14 EIF2B1 SMARCA1 UHRF1 UTP20 PDS5A PNPLA8 KIF5B MYO18B PSPC1 GOLGA4 | 6.64e-08 | 1425 | 164 | 24 | 30948266 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | GPD2 CAD EIF4H MYO5A CENPF NOC2L MARS1 HAUS5 PRPF8 RAD50 CKB SMPDL3B MYH14 PLEKHG3 UHRF1 UTP20 CTNNA1 KIF5B HERC2 PSPC1 | 8.88e-08 | 1024 | 164 | 20 | 24711643 |
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | KRT13 EIF4H CENPF PRPF8 RAD50 CKB PDE12 SRGAP3 SGPL1 AP3B2 PNPLA8 CTNNA1 KIF5B PSPC1 | 1.18e-07 | 498 | 164 | 14 | 36634849 |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | KRT13 CAD MAP7D3 MYO5A CENPF NOC2L MARS1 PKP4 TUT7 PHB2 KRR1 PRPF8 RAD50 UPF2 PLEKHG3 SGPL1 SMARCA1 UTP20 CTNNA1 KIF5B PSPC1 | 5.43e-07 | 1257 | 164 | 21 | 36526897 |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | CAD MAP7D3 MYO5A MARS1 PHB2 PRPF8 DENND2B ITPR1 SMTN GNG12 MYH14 PLEKHG3 EIF2B1 MRPS15 UHRF1 UTP20 CTNNA1 KIF5B | 6.25e-07 | 949 | 164 | 18 | 36574265 |
| Pubmed | SH3TC2 CLIP2 DYNC2H1 CCDC85A SAMD9L SCAP LMBR1L PLEKHG3 SGPL1 WDR35 PDS5A ZNF518B HECTD1 | 7.00e-07 | 493 | 164 | 13 | 15368895 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | CENPF MARS1 OBSCN AK9 NEB PRPF8 CBR3 MAP3K4 DIP2A TRANK1 PIK3C2B CTNNA1 ATP2A3 | 7.66e-07 | 497 | 164 | 13 | 36774506 |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | CAD CENPF PHB2 PRPF8 MAP3K4 POLR3A RAD50 PDE12 UPF2 MRPS15 SMARCA1 UTP20 PDS5A KIF5B ATP2A3 | 1.38e-06 | 704 | 164 | 15 | 29955894 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | SLC37A1 COL26A1 MYO5A MARS1 OBSCN SHROOM2 DENND2B DNAH14 PCNX2 PTPN13 SMPDL3B FAM13A GNG12 MYH14 PLEKHG3 RALGPS1 ANKIB1 KCNN2 QSER1 CROCC HECTD1 GOLGA4 | 2.17e-06 | 1489 | 164 | 22 | 28611215 |
| Pubmed | MCHR1 GIT1 MYO5A CLIP2 ABCC5 ZNF227 REV3L PRPF8 SHROOM2 CBR3 CCDC85A DIP2A PTPN13 MYH14 DAAM2 CTNNA1 HERC2 CTNND2 LNX1 HECTD1 | 3.03e-06 | 1285 | 164 | 20 | 35914814 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | LCA5 MAP7D3 EIF4H GIT1 NOC2L BACH2 PKP4 TUT7 HAUS5 ATG2A RAD50 CKB CEP250 KIF5B HERC2 TP53BP2 | 3.14e-06 | 853 | 164 | 16 | 28718761 |
| Pubmed | 3.55e-06 | 7 | 164 | 3 | 25009281 | ||
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | LCA5 IFT140 MAP7D3 GIT1 DYNC2H1 PHB2 XPO4 TBC1D25 PRPF8 RAD50 RNF214 PTPN13 NRXN1 EIF2B1 CCDC154 WDR35 CTNNA1 QSER1 TP53BP2 CCDC40 | 4.57e-06 | 1321 | 164 | 20 | 27173435 |
| Pubmed | GPD2 CAD NOC2L MARS1 PHB2 XPO4 FAM98B KRR1 PRPF8 POLR3A ITPR1 SMTN RAD50 CKB GNG12 PLEKHG3 SGPL1 EIF2B1 MRPS15 PDS5A CTNNA1 | 4.61e-06 | 1440 | 164 | 21 | 30833792 | |
| Pubmed | 5.67e-06 | 8 | 164 | 3 | 15802388 | ||
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 5.67e-06 | 202 | 164 | 8 | 33005030 | |
| Pubmed | A directed protein interaction network for investigating intracellular signal transduction. | IFT140 GIT1 MARS1 CCDC186 PKP4 HAUS5 UBXN6 ZNF227 CCDC85A CKB DUS2 RASSF1 PDS5A ALAS1 CTNNA1 KIF5B CTNND2 TP53BP2 | 6.65e-06 | 1124 | 164 | 18 | 21900206 |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | DAGLB DYNC2H1 NOC2L MARS1 TUT7 PHB2 NCSTN PDE12 SCAP LMBR1L UTP20 PDS5A CTNNA1 KIF5B HECTD1 SYMPK | 1.08e-05 | 942 | 164 | 16 | 31073040 |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | EIF4H HAUS5 PHB2 FAM98B PRPF8 POLR3A RAD50 CKB UPF2 MYH14 CEP250 AP3B2 MRPS15 KIF5B PSPC1 | 1.27e-05 | 847 | 164 | 15 | 35235311 |
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | EIF4H MYO5A CENPF TUT7 XPO4 RAD50 PTPN13 MYH14 EIF2B1 CEP250 MRPS15 UTP20 HERC2 HECTD1 | 1.49e-05 | 754 | 164 | 14 | 33060197 |
| Pubmed | Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways. | KRT13 CAD LDHAL6A MYO5A OBSCN PHB2 SMTN CKB PTPN13 SGPL1 WDR35 GOLGA4 | 1.65e-05 | 564 | 164 | 12 | 21565611 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | ABCC3 OBSCN TBC1D25 LRRK1 ATG2A REV3L CTDSP2 PCNX2 DIP2A SCAP PIK3C2B RALGPS1 HERC2 HECTD1 ATP2A3 ABCC10 SYMPK | 2.03e-05 | 1105 | 164 | 17 | 35748872 |
| Pubmed | IFT140 KRT13 CLIP2 CCDC186 NEB MAP3K4 CEP250 BICRAL CTNNA1 KIF5B HERC2 | 2.14e-05 | 486 | 164 | 11 | 20936779 | |
| Pubmed | 2.21e-05 | 2 | 164 | 2 | 10340910 | ||
| Pubmed | 2.21e-05 | 2 | 164 | 2 | 16339073 | ||
| Pubmed | C-NAP1 and rootletin restrain DNA damage-induced centriole splitting and facilitate ciliogenesis. | 2.21e-05 | 2 | 164 | 2 | 23070519 | |
| Pubmed | 2.21e-05 | 2 | 164 | 2 | 10413599 | ||
| Pubmed | Functional cloning of SPIN-2, a nuclear anti-apoptotic protein with roles in cell cycle progression. | 2.21e-05 | 2 | 164 | 2 | 12145692 | |
| Pubmed | 2.21e-05 | 2 | 164 | 2 | 15688370 | ||
| Pubmed | 2.21e-05 | 2 | 164 | 2 | 34042275 | ||
| Pubmed | 2.21e-05 | 2 | 164 | 2 | 9342840 | ||
| Pubmed | 2.21e-05 | 2 | 164 | 2 | 9827529 | ||
| Pubmed | Exome sequencing reveals pathogenic mutations in 91 strains of mice with Mendelian disorders. | 2.38e-05 | 72 | 164 | 5 | 25917818 | |
| Pubmed | Mammalian APE1 controls miRNA processing and its interactome is linked to cancer RNA metabolism. | GIT1 MYO5A CLIP2 PKP4 UBXN6 R3HCC1 TBC1D25 DNAH14 CTDSP2 SMTN DIP2A UHRF1 KIF13A ABCC10 FILIP1L | 3.52e-05 | 925 | 164 | 15 | 28986522 |
| Pubmed | SLC37A1 CAD MAP7D3 EIF4H GIT1 MYO5A MARS1 ACOX1 NCSTN KRR1 PRPF8 POLR3A ITPR1 RAD50 MYH14 KIF5B HERC2 | 4.06e-05 | 1168 | 164 | 17 | 19946888 | |
| Pubmed | GIT1 CLIP2 PHB2 PTPN13 SRGAP3 SGPL1 CEP250 AP3B2 PNPLA8 HERC2 | 4.07e-05 | 430 | 164 | 10 | 32581705 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | GPD2 KRT13 CAD GIT1 MARS1 POLR2J PHB2 FAM98B KRR1 PRPF8 RAD50 CKB PDS5A CTNNA1 KIF5B TRIM47 PSPC1 HECTD1 GOLGA4 | 4.19e-05 | 1415 | 164 | 19 | 28515276 |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | 4.93e-05 | 440 | 164 | 10 | 34244565 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | CENPF OBSCN REV3L PRPF8 DNAH14 DIP2A SAMD9L PDE12 SRGAP3 UBAC1 UTP20 PDS5A SYMPK | 5.05e-05 | 736 | 164 | 13 | 29676528 |
| Pubmed | MAP7D3 EIF4H GIT1 HAUS5 PHB2 RAD50 CDAN1 GNG12 MYH14 UHRF1 KIF5B TP53BP2 | 6.06e-05 | 645 | 164 | 12 | 25281560 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | MAP7D3 GIT1 DENND2B FSIP2 PTPN13 FAM13A PIK3C2B PLEKHG3 KIF5B KIF13A HECTD1 MUSK GOLGA4 TP53BP2 | 6.28e-05 | 861 | 164 | 14 | 36931259 |
| Pubmed | Simultaneous expression of COX-2 and mPGES-1 in mouse gastrointestinal hamartomas. | 6.61e-05 | 3 | 164 | 2 | 14760387 | |
| Pubmed | 6.61e-05 | 3 | 164 | 2 | 9270026 | ||
| Pubmed | 6.61e-05 | 3 | 164 | 2 | 23108400 | ||
| Pubmed | 6.61e-05 | 3 | 164 | 2 | 19077464 | ||
| Pubmed | KRT13, FAIM2 and CYP2W1 mRNA expression in oral squamous cell carcinoma patients with risk habits. | 6.61e-05 | 3 | 164 | 2 | 25735388 | |
| Pubmed | 6.61e-05 | 3 | 164 | 2 | 10896674 | ||
| Pubmed | 6.61e-05 | 3 | 164 | 2 | 25660448 | ||
| Pubmed | 6.61e-05 | 3 | 164 | 2 | 25908617 | ||
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | MAP7D3 MYO5A CENPF NOC2L TUT7 KRR1 PRPF8 UPF2 EIF2B1 UHRF1 UTP20 HERC2 HECTD1 | 6.89e-05 | 759 | 164 | 13 | 35915203 |
| Pubmed | Comprehensive Proteomic Analysis of PGC7-Interacting Proteins. | 7.01e-05 | 287 | 164 | 8 | 28712289 | |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | DYNC2H1 ATG2A KRR1 PRPF8 CBR3 POLR3A RAD50 CKB STK11 PDE12 RIMBP2 KIF5B MPND HERC2 HECTD1 | 8.91e-05 | 1005 | 164 | 15 | 19615732 |
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | DYNC2H1 UBXN6 NCSTN NEB SHROOM2 CKB STK11 PTPN13 SMPDL3B GNG12 MYH14 CEP250 UBAC1 CROCC CCDC180 | 1.00e-04 | 1016 | 164 | 15 | 19056867 |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | GIT1 NOC2L MARS1 PHB2 XPO4 LRRK1 FAM98B PRPF8 RAD50 CDAN1 EIF2B1 UBAC1 PDS5A KIF5B HERC2 ATP2A3 UNC79 | 1.28e-04 | 1284 | 164 | 17 | 17353931 |
| Pubmed | TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions. | CAD EIF4H PKP4 POLR2J PHB2 REV3L PRPF8 CKB STK11 PTPN13 WDR35 HERC2 PSPC1 SYMPK | 1.29e-04 | 922 | 164 | 14 | 27609421 |
| Pubmed | 1.30e-04 | 234 | 164 | 7 | 36243803 | ||
| Pubmed | 1.32e-04 | 4 | 164 | 2 | 10856712 | ||
| Pubmed | Recurrent CNVs disrupt three candidate genes in schizophrenia patients. | 1.32e-04 | 4 | 164 | 2 | 18940311 | |
| Pubmed | 1.32e-04 | 4 | 164 | 2 | 11124535 | ||
| Pubmed | Myosin5a tail associates directly with Rab3A-containing compartments in neurons. | 1.32e-04 | 4 | 164 | 2 | 21349835 | |
| Pubmed | 1.32e-04 | 4 | 164 | 2 | 18483150 | ||
| Pubmed | 1.32e-04 | 4 | 164 | 2 | 26147384 | ||
| Pubmed | 1.32e-04 | 4 | 164 | 2 | 19956884 | ||
| Pubmed | 1.32e-04 | 4 | 164 | 2 | 19706687 | ||
| Pubmed | 1.38e-04 | 104 | 164 | 5 | 9205841 | ||
| Pubmed | CAD GIT1 FAM98B PRPF8 RAD50 RNF214 MYH14 SGPL1 SMARCA1 UHRF1 PSPC1 | 1.42e-04 | 601 | 164 | 11 | 33658012 | |
| Pubmed | GPD2 CAD MYO5A PKP4 XPO4 PPEF2 CTDSP2 ITPR1 VIPAS39 PTPN13 CTNNA1 HERC2 GOLGA4 TP53BP2 SYMPK | 1.42e-04 | 1049 | 164 | 15 | 27880917 | |
| Pubmed | 1.48e-04 | 22 | 164 | 3 | 8894702 | ||
| Pubmed | The midnolin-proteasome pathway catches proteins for ubiquitination-independent degradation. | CLIP2 NOC2L PHB2 NCSTN RAD50 CKB PTPN13 SMPDL3B GNG12 CTNNA1 PSPC1 | 1.49e-04 | 604 | 164 | 11 | 37616343 |
| Pubmed | CAD SLF1 MYO5A MARS1 PHB2 KRR1 RAD50 CKB RNF214 GNG12 MYH14 MRPS15 SMARCA1 PDS5A QSER1 HERC2 FILIP1L SYMPK | 1.50e-04 | 1429 | 164 | 18 | 35140242 | |
| Pubmed | GPD2 ATG2A CTDSP2 ITPR1 SLC7A2 VIPAS39 PTPN13 SCAP SGPL1 GOLGA4 | 1.50e-04 | 504 | 164 | 10 | 34432599 | |
| Pubmed | 1.68e-04 | 171 | 164 | 6 | 36629882 | ||
| Pubmed | 1.70e-04 | 23 | 164 | 3 | 25523391 | ||
| Pubmed | 1.79e-04 | 173 | 164 | 6 | 36217029 | ||
| Pubmed | Proteomics strategy to identify substrates of LNX, a PDZ domain-containing E3 ubiquitin ligase. | 1.89e-04 | 60 | 164 | 4 | 22889411 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | ABCC3 P3H3 TUT7 NCSTN ITGA7 ITPR1 SCAP SGPL1 UHRF1 UTP20 CTNNA1 KIF5B HECTD1 ATP2A3 FKBP2 SYMPK | 1.90e-04 | 1201 | 164 | 16 | 35696571 |
| Pubmed | 1.95e-04 | 250 | 164 | 7 | 33536335 | ||
| Pubmed | MARS1 TUT7 OBSCN NCSTN KRR1 SHROOM2 ITPR1 SMTN STK11 PTPN13 SCAP SGPL1 RASSF1 QSER1 KIF13A | 2.03e-04 | 1084 | 164 | 15 | 11544199 | |
| Pubmed | 2.19e-04 | 5 | 164 | 2 | 10037471 | ||
| Pubmed | Chromosomal mapping of human armadillo genes belonging to the p120(ctn)/plakophilin subfamily. | 2.19e-04 | 5 | 164 | 2 | 9721216 | |
| Pubmed | 2.19e-04 | 5 | 164 | 2 | 30617251 | ||
| Pubmed | CCDC102B functions in centrosome linker assembly and centrosome cohesion. | 2.19e-04 | 5 | 164 | 2 | 30404835 | |
| Pubmed | The kinase domains of obscurin interact with intercellular adhesion proteins. | 2.19e-04 | 5 | 164 | 2 | 23392350 | |
| Pubmed | Efflux protein expression in human stem cell-derived retinal pigment epithelial cells. | 2.19e-04 | 5 | 164 | 2 | 22272278 | |
| Pubmed | Centlein mediates an interaction between C-Nap1 and Cep68 to maintain centrosome cohesion. | 2.19e-04 | 5 | 164 | 2 | 24554434 | |
| Pubmed | 2.20e-04 | 255 | 164 | 7 | 15324660 | ||
| Pubmed | DENND2A IFT140 HAUS5 XPO4 LRRK1 NCSTN ATG2A TRANK1 RALGPS1 ANKIB1 | 2.21e-04 | 529 | 164 | 10 | 14621295 | |
| Pubmed | KRT13 CAD EIF4H MYO5A DYNC2H1 NOC2L PKP4 PHB2 PRPF8 ITPR1 DIP2A PTPN13 PDE12 PNPLA8 ALAS1 CTNNA1 HERC2 GOLGA4 | 2.44e-04 | 1487 | 164 | 18 | 33957083 | |
| Pubmed | 2.52e-04 | 346 | 164 | 8 | 25324306 | ||
| Pubmed | 2.57e-04 | 347 | 164 | 8 | 17114649 | ||
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | GPD2 CAD MAP7D3 CENPF TUT7 PHB2 POLR3A ITPR1 CKB DIP2A VIPAS39 PDE12 UPF2 MRPS15 PNPLA8 ALAS1 HERC2 PSPC1 | 2.62e-04 | 1496 | 164 | 18 | 32877691 |
| Pubmed | Histone methyltransferase DOT1L coordinates AR and MYC stability in prostate cancer. | 2.71e-04 | 264 | 164 | 7 | 32814769 | |
| Pubmed | CLIP2 TUT7 PHB2 FAM98B KRR1 PRPF8 CKB DUS2 UPF2 MYH14 EHHADH EIF2B1 SMARCA1 UHRF1 KIF5B HERC2 PSPC1 | 2.77e-04 | 1371 | 164 | 17 | 36244648 | |
| Pubmed | A germline-specific class of small RNAs binds mammalian Piwi proteins. | 3.04e-04 | 450 | 164 | 9 | 16751776 | |
| Pubmed | Loss of LKB1 leads to impaired epithelial integrity and cell extrusion in the early mouse embryo. | 3.09e-04 | 28 | 164 | 3 | 25588837 | |
| Interaction | GSK3B interactions | GPD2 CDX2 CAD MAP7D3 EIF4H MARS1 HAUS5 UBXN6 ZNF227 MAP3K4 STK11 PTPN13 GNG12 LMBR1L RASSF1 UHRF1 CTNNA1 KIF5B HERC2 CTNND2 HECTD1 TP53BP2 | 1.65e-06 | 868 | 161 | 22 | int:GSK3B |
| Interaction | TMOD4 interactions | 3.11e-06 | 29 | 161 | 5 | int:TMOD4 | |
| Interaction | KCTD13 interactions | GPD2 DENND2A CAD GIT1 MYO5A CLIP2 MARS1 PKP4 PHB2 FAM98B SHROOM2 CKB DIP2A UPF2 MYH14 SRGAP3 SGPL1 AP3B2 PACS2 RIMBP2 CTNNA1 KIF5B CTNND2 CROCC LNX1 PSPC1 TP53BP2 | 1.57e-05 | 1394 | 161 | 27 | int:KCTD13 |
| Interaction | YWHAZ interactions | LCA5 CAD MAP7D3 GIT1 MYO5A CLIP2 KRR1 NEB PRPF8 DENND2B THAP9 MAP3K4 ITPR1 FSIP2 PTPN13 FAM13A NRXN1 PIK3C2B SRGAP3 PLEKHG3 PACS2 KIF5B HERC2 LNX1 HECTD1 TP53BP2 | 1.70e-05 | 1319 | 161 | 26 | int:YWHAZ |
| Interaction | HOOK1 interactions | 2.40e-05 | 240 | 161 | 10 | int:HOOK1 | |
| Cytoband | Xp11.1 | 7.57e-05 | 4 | 164 | 2 | Xp11.1 | |
| GeneFamily | ATP binding cassette subfamily C | 4.12e-05 | 13 | 97 | 3 | 807 | |
| GeneFamily | Ankyrin repeat domain containing | 4.76e-05 | 242 | 97 | 8 | 403 | |
| GeneFamily | Tudor domain containing|Spindlin family | 2.82e-04 | 5 | 97 | 2 | 1089 | |
| GeneFamily | EMI domain containing | 5.88e-04 | 7 | 97 | 2 | 540 | |
| GeneFamily | Tudor domain containing | 1.02e-03 | 37 | 97 | 3 | 780 | |
| GeneFamily | PDZ domain containing | 1.36e-03 | 152 | 97 | 5 | 1220 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 2.92e-03 | 181 | 97 | 5 | 694 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | SLC37A1 CELF6 MYO5A PILRB CCDC186 BACH2 ABCC5 REV3L NEB SHROOM2 CCDC85A FSIP2 NRXN1 SRGAP3 RALGPS1 AP3B2 ANKIB1 RIMBP2 FRMPD3 CTNND2 KIF13A UNC79 | 1.67e-06 | 1106 | 164 | 22 | M39071 |
| Coexpression | TCGA_GLIOBLASTOMA_COPY_NUMBER_UP | 7.72e-06 | 75 | 164 | 6 | M5536 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.76e-08 | 195 | 164 | 9 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.76e-08 | 195 | 164 | 9 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | Epithelial-Epithelial-D_(Ciliated)|Epithelial / shred on cell class and cell subclass (v4) | 5.01e-07 | 188 | 164 | 8 | 8f30535a32968a81a304315a49c0d90a77d36948 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.65e-07 | 191 | 164 | 8 | 09db184cb90fe282a14474d7217068c58092c6f8 | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_prolif|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.68e-06 | 173 | 164 | 7 | 12f779b8dce79431b2d1002ba524dd3f9566aeb0 | |
| ToppCell | droplet-Lung-1m-Mesenchymal-myofibroblast-pericyte_cell-pericyte|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.53e-06 | 184 | 164 | 7 | 4cb5f299dd7413e0be1ad7af817ee614b23a18ae | |
| ToppCell | droplet-Lung-1m-Mesenchymal-myofibroblast-pericyte_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.53e-06 | 184 | 164 | 7 | 39bb0eb55bdc2cea46e41c7f21d8c5883f14e6bd | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.15e-06 | 187 | 164 | 7 | 7ea8731288e2a99f45e3958590ee1d76f49ae888 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-I_(AT1)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 6.36e-06 | 188 | 164 | 7 | c74771584b3ba9561a99a54bf55a9203ddf8eff8 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-I_(AT1)|368C / Donor, Lineage, Cell class and subclass (all cells) | 6.36e-06 | 188 | 164 | 7 | 9155b9a92496e75646778c025b02947e9e9ec73a | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.82e-06 | 190 | 164 | 7 | 3dcadabbefe0128a5f30ab51234f049ab4d870c6 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.06e-06 | 191 | 164 | 7 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.06e-06 | 191 | 164 | 7 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.30e-06 | 192 | 164 | 7 | 562df5e87038c500dd3a003fe5374cb31946b145 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.81e-06 | 194 | 164 | 7 | e3d63874111d1e8da3977329426e4dcf68d6de87 | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-Tuft-related-BEST4+_epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.92e-06 | 198 | 164 | 7 | efdbac7a3a02bff4ca48841772e0c136556c2b9b | |
| ToppCell | control|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 9.53e-06 | 200 | 164 | 7 | 97f36d2c197e03d93a1fc59949d77ae90f6e6a9a | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Peri/Epineurial_|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 9.53e-06 | 200 | 164 | 7 | f7c3a8f5ac156c05ad7335d6d142c154c7d86449 | |
| ToppCell | mild_COVID-19_(asymptomatic)-NK_CD56bright|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 2.06e-05 | 151 | 164 | 6 | 2470162f4b56bc505db166a6eb0fa54847759df8 | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.14e-05 | 152 | 164 | 6 | 82a493ffb2f1704cd6f68a82d970fe12f537d20e | |
| ToppCell | 368C-Myeloid-Monocyte-CD16+_Monocyte|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.48e-05 | 156 | 164 | 6 | 25b0936960be4955b6a6d6b8a867fdd4be548f05 | |
| ToppCell | Control-B_intermediate-1|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.63e-05 | 167 | 164 | 6 | 948504367ecf58144d9dd74d2ec531358fc4b309 | |
| ToppCell | P15-Epithelial-airway_epithelial_cell-ciliated_cell_of_airway|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.63e-05 | 167 | 164 | 6 | 5c3d0763f73628c71c71f9883556bb4f1639f3cc | |
| ToppCell | PND03-Immune-Immune_Myeloid-DC-cDC2-cDC2_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.75e-05 | 168 | 164 | 6 | cc0dd43d5cda01e643d8e8d74ec7617d61890760 | |
| ToppCell | facs-Heart-LV-18m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.42e-05 | 173 | 164 | 6 | d78397e65e997ddb995111a810f0e2a4f67d0765 | |
| ToppCell | facs-Heart-LV-18m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.42e-05 | 173 | 164 | 6 | 3c852ffe22f4a5b632463086b08c669310684e80 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Epithelial-epithelial_progenitor_cell-Distal_progenitor|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.42e-05 | 173 | 164 | 6 | 81c36b9fe02c59099f080b2db02f4eaf2783911f | |
| ToppCell | facs-Limb_Muscle-Muscle_Diaphragm-18m-Lymphocytic-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.71e-05 | 175 | 164 | 6 | db6be3e9e339918418fcaf9001ea15207aa6c993 | |
| ToppCell | facs-Limb_Muscle-Muscle_Diaphragm-18m-Lymphocytic|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.71e-05 | 175 | 164 | 6 | 8acac10c9eedccebcf3a3fe31bfee35afa54579f | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.02e-05 | 177 | 164 | 6 | 4553ee8cd9c24db6511b09fe49ed11a89e7cde9e | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.18e-05 | 178 | 164 | 6 | 066dbc4cc2083c549d98122ed44707127f34d582 | |
| ToppCell | Control-Endothelial_cells-Capillary_endothelial_cells|Control / group, cell type (main and fine annotations) | 5.51e-05 | 180 | 164 | 6 | b043f9ffb9a4cd427a15bebb86a711c7b08866e8 | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-alveolar_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.68e-05 | 181 | 164 | 6 | 8fcdab61fad2efd324d2b27c58f5a594f1dc15de | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.86e-05 | 182 | 164 | 6 | 9edaccf1154cec92ca9a28e9b1f9075cfd422bfd | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.86e-05 | 182 | 164 | 6 | aba4c06d5d7618ac21b2695bca8e7a1346a91090 | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.86e-05 | 182 | 164 | 6 | be48ce85991bceeff938ba080e6bf9cc62176b05 | |
| ToppCell | facs-Heart-RA-18m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.04e-05 | 183 | 164 | 6 | 0f02136359787bd78146617990968baa47a65d86 | |
| ToppCell | facs-Heart-RA-18m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.04e-05 | 183 | 164 | 6 | 2f0dcc65ad4d90ef946919b4462280fdd20c5ea0 | |
| ToppCell | COVID-19-Fibroblasts-Pericytes|COVID-19 / group, cell type (main and fine annotations) | 6.41e-05 | 185 | 164 | 6 | 4905adaeeffd353e089578e5ea614437dbe794e6 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.61e-05 | 186 | 164 | 6 | bdbe290f81106a53c8c30a92fbb385597c62b2ac | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.80e-05 | 187 | 164 | 6 | f18628ffc7ff7c762b8339ba8822cf0c3157f469 | |
| ToppCell | ILEUM-inflamed-(3)_MNP-(3)_moDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 6.80e-05 | 187 | 164 | 6 | 0099def970fbc828756fbf853eca2ce77b8cd342 | |
| ToppCell | facs-Heart-LA-18m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.80e-05 | 187 | 164 | 6 | f1e9877d859369b862d4a559ec9ab9be74a67a96 | |
| ToppCell | facs-Heart-LA-18m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.80e-05 | 187 | 164 | 6 | 3ffbd50b49059dcd3e23c5ac01901e4352142446 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.01e-05 | 188 | 164 | 6 | 2ee64bc73a2251fd9f374be759b442cf4ed0d19e | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.01e-05 | 188 | 164 | 6 | 997dcfc4f08738ab398d8abc15e4fd2fc6619862 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.01e-05 | 188 | 164 | 6 | 3cee9916399e2e7580cecbcbb27424a71e7e7ac0 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.22e-05 | 189 | 164 | 6 | f51cdc9a47371cab8ed9ae63a6f14da07ede446c | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.22e-05 | 189 | 164 | 6 | de51fbd6fdb24fc4549393cf41a020005444b2aa | |
| ToppCell | cellseq2-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-VEC|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.22e-05 | 189 | 164 | 6 | bccb3481ffed597c845fe860da658505316105b5 | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary-CAP2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.22e-05 | 189 | 164 | 6 | b6b4da51bc7f2c13a2f940540fdc61027d084835 | |
| ToppCell | Mesenchymal-pericyte_cell|World / Lineage, Cell type, age group and donor | 7.22e-05 | 189 | 164 | 6 | d7ed96add29f219183c802895fbff519b627f635 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.43e-05 | 190 | 164 | 6 | 1d8e169d2448a34180c415843bb49aa45ed540c5 | |
| ToppCell | IPF-Endothelial-VE_Arterial|Endothelial / Disease state, Lineage and Cell class | 7.87e-05 | 192 | 164 | 6 | e911e286da26202853f9650ba3cdefe5a5c9b585 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.87e-05 | 192 | 164 | 6 | 992d08092edbc68c47b945deb8708379738c239a | |
| ToppCell | COVID-19-kidney-CNT|kidney / Disease (COVID-19 only), tissue and cell type | 7.87e-05 | 192 | 164 | 6 | d32ae226d95b4b6adb99d14b602be09b661d4cd9 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.10e-05 | 193 | 164 | 6 | 02f633b016ab19bfa65bfd0cf32f000549a62148 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Gen_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.10e-05 | 193 | 164 | 6 | af5108260783e69a7d67896c5bf64f862525926d | |
| ToppCell | LPS-antiTNF-Endothelial|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.10e-05 | 193 | 164 | 6 | 5122b1ffba42de190061be34ecdc6176f84e56a3 | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.10e-05 | 193 | 164 | 6 | 0266a4fdf436d83ec1d9392abba8c6ec5166970a | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.10e-05 | 193 | 164 | 6 | 7386fadc13a437f3b0c99b5d116cd3c5f893529c | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.33e-05 | 194 | 164 | 6 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f | |
| ToppCell | LPS_only-Endothelial|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.33e-05 | 194 | 164 | 6 | 58f069efdefa0366033764446b9d6ffd4a17807e | |
| ToppCell | LPS_only-Endothelial-Endothelial|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.33e-05 | 194 | 164 | 6 | bfd92ec75facb0ba55c31e5f2e089d983b3d0169 | |
| ToppCell | moderate-Epithelial-Ciliated|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 8.57e-05 | 195 | 164 | 6 | e80f5cdf0b18066b3e6c2f5452e58f101c67932c | |
| ToppCell | critical-Epithelial-Ciliated|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 8.82e-05 | 196 | 164 | 6 | 27b855c6e1ae44f16db998cf0e81bd686b9cee7e | |
| ToppCell | Parenchymal-NucSeq-Stromal-Pericyte-Muscle_pericyte_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.06e-05 | 197 | 164 | 6 | f66945f9007d59d4208849c7fd727f8519713fbc | |
| ToppCell | Parenchymal-NucSeq-Stromal-Pericyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.06e-05 | 197 | 164 | 6 | 41dd312f46a2b983c8d864adeb6970c0ca4a8048 | |
| ToppCell | Transverse-(5)_Dendritic_cell-(53)_Lymphoid_DC|Transverse / shred on region, Cell_type, and subtype | 9.06e-05 | 197 | 164 | 6 | 15b87fd3906d7388c271d30d0c64b1bcc490801c | |
| ToppCell | Transverse-Dendritic_cell-Lymphoid_DC|Transverse / Region, Cell class and subclass | 9.06e-05 | 197 | 164 | 6 | a58af0ea82f76f2a7abac1f62629ff20d552fc63 | |
| ToppCell | critical-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 9.32e-05 | 198 | 164 | 6 | ee2c8385c0bf4ea9f5c9517b52cf131af3fbdd40 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like-AC-like-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.32e-05 | 198 | 164 | 6 | 01d563ccdc0da02dac04169e713844fecb4233a1 | |
| ToppCell | Tracheal-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.32e-05 | 198 | 164 | 6 | 1e1ea54f0c234f3b6d29064c4881d8a0c0949a75 | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 9.58e-05 | 199 | 164 | 6 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like-AC-like|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.58e-05 | 199 | 164 | 6 | 04e5cfb85c681fd3f4c1151062e4a0f460b55d5f | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors|1_mon / Sample Type, Dataset, Time_group, and Cell type. | 9.58e-05 | 199 | 164 | 6 | 358c4b3037f59378db8916a2fbe9ed4830cf1449 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-NPC-like-NPC-like_Prolif-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.58e-05 | 199 | 164 | 6 | 53b3d35767889a152f1f38e8f6f0ba8f7a7690f2 | |
| ToppCell | cellseq2-Mesenchymal-Myocytic-Myocytic_2-VSMC|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.85e-05 | 200 | 164 | 6 | fc802dd73f048881d9ddafd1b79ab3ca654510e2 | |
| ToppCell | cellseq2-Mesenchymal-Myocytic-Myocytic_2|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.85e-05 | 200 | 164 | 6 | cffddb39960cd611428397c1ec4023192e8af5a7 | |
| ToppCell | Parenchymal-10x5prime-Immune_Myeloid-Macrophage_alveolar-Macro_alv_dividing|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.85e-05 | 200 | 164 | 6 | 0cf7208eab0dc58fbea35e256c5cb55cdd4a4928 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Smooth_muscle-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 9.85e-05 | 200 | 164 | 6 | 0c648941447c738caf62f2d71e296d6cca492c8b | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 9.85e-05 | 200 | 164 | 6 | bcd1cc96197929d6011903803b6f4ccdcf52b4ce | |
| ToppCell | cellseq2-Mesenchymal|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.85e-05 | 200 | 164 | 6 | 6b558cce0d6047c7e85f428adff80c5ca3084ea4 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 9.85e-05 | 200 | 164 | 6 | 2d07237022b409c4fac6fcf99b68c8affb3007cd | |
| ToppCell | Sepsis-Int-URO-Lymphocyte-T/NK-dn_T|Int-URO / Disease, condition lineage and cell class | 9.85e-05 | 200 | 164 | 6 | 020439d9e70fff7246650ab0e9105236688c3ec3 | |
| ToppCell | cellseq2-Mesenchymal-Myocytic|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.85e-05 | 200 | 164 | 6 | e60aebd20be8012fa2febf6585ed34ebd64ec9b3 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.85e-05 | 200 | 164 | 6 | 522a51a284d2992d519c4669e1a48c8ebcc08c80 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Activated_Gen_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 9.85e-05 | 200 | 164 | 6 | f15fffefe372005c33e31845982e2d2714ac26af | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.85e-05 | 200 | 164 | 6 | 94f1fa61aa82eb9f411b2b1cb759476939ab5db7 | |
| ToppCell | NS-control|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 9.85e-05 | 200 | 164 | 6 | ecbe89ff95d046155b984c8c150e0b9e7278f839 | |
| ToppCell | TCGA-Mesothelium-Primary_Tumor-Mesothelioma-Epitheliod-3|TCGA-Mesothelium / Sample_Type by Project: Shred V9 | 1.53e-04 | 137 | 164 | 5 | a1e34ebbeda3d5a4f14917282d44fcb4dcbf3133 | |
| ToppCell | LPS_only-Hematopoietic_Erythro-Megakary-Erythro-Mega-Platelets|LPS_only / Treatment groups by lineage, cell group, cell type | 1.59e-04 | 138 | 164 | 5 | 6ddd50e44a3914596b4cd61ae64a987119fe7979 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-I_(AT1)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.64e-04 | 139 | 164 | 5 | 39f3c28f89c37bb8cc049c56d2948ea906fb3d86 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-I_(AT1)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.64e-04 | 139 | 164 | 5 | 4efab4421e3448880a1dcf981f6a65131b038010 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Epi-like-Gen_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.81e-04 | 142 | 164 | 5 | d52da766e031f7409eb5a7a9fa88f48e14a79d8b | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Epi-like|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.81e-04 | 142 | 164 | 5 | a05b320cf182b2aaf18df7c40045dc65b659bf20 | |
| Drug | 5211181; Up 200; 12uM; MCF7; HT_HG-U133A_EA | GIT1 DYNC2H1 HAUS5 ITPR1 CKB PDE12 SGPL1 RALGPS1 RASSF1 SYMPK | 1.58e-06 | 195 | 164 | 10 | 834_UP |
| Drug | Amphotericin B [1397-89-3]; Down 200; 4.4uM; MCF7; HT_HG-U133A | 1.19e-05 | 194 | 164 | 9 | 3303_DN | |
| Drug | (S)-(-)-Cycloserine [339-72-0]; Down 200; 39.2uM; PC3; HT_HG-U133A | 1.19e-05 | 194 | 164 | 9 | 4524_DN | |
| Drug | Strophanthidin [66-28-4]; Down 200; 9.8uM; PC3; HT_HG-U133A | 1.19e-05 | 194 | 164 | 9 | 5826_DN | |
| Drug | Cyproheptadine hydrochloride [969-33-5]; Down 200; 12.4uM; MCF7; HT_HG-U133A | 1.35e-05 | 197 | 164 | 9 | 5340_DN | |
| Drug | Josamycin [16846-24-5]; Down 200; 4.8uM; PC3; HT_HG-U133A | 1.35e-05 | 197 | 164 | 9 | 4631_DN | |
| Drug | Amoxicillin [26787-78-0]; Up 200; 11uM; PC3; HT_HG-U133A | 1.46e-05 | 199 | 164 | 9 | 6285_UP | |
| Drug | Vincamine [1617-90-9]; Up 200; 11.2uM; HL60; HT_HG-U133A | 1.46e-05 | 199 | 164 | 9 | 2367_UP | |
| Disease | Short Rib-Polydactyly Syndrome | 4.63e-05 | 13 | 164 | 3 | C0036996 | |
| Disease | Saldino-Noonan Syndrome | 5.87e-05 | 14 | 164 | 3 | C0036069 | |
| Disease | Majewski Syndrome | 5.87e-05 | 14 | 164 | 3 | C0024507 | |
| Disease | Short rib-polydactyly syndrome, Verma-Naumoff type | 3.04e-04 | 5 | 164 | 2 | C0432197 | |
| Disease | triacylglycerol 58:10 measurement | 8.89e-04 | 34 | 164 | 3 | EFO_0010437 | |
| Disease | Jeune thoracic dystrophy | 1.63e-03 | 11 | 164 | 2 | C0265275 | |
| Disease | Charcot-Marie-Tooth disease | 1.65e-03 | 42 | 164 | 3 | cv:C0007959 | |
| Disease | level of Sphingomyelin (d34:2) in blood serum | 2.30e-03 | 13 | 164 | 2 | OBA_2045174 | |
| Disease | reading and spelling ability | 2.40e-03 | 166 | 164 | 5 | EFO_0005301 | |
| Disease | Williams-Beuren syndrome (implicated_via_orthology) | 3.07e-03 | 15 | 164 | 2 | DOID:1928 (implicated_via_orthology) | |
| Disease | myelodysplastic syndrome (implicated_via_orthology) | 3.07e-03 | 15 | 164 | 2 | DOID:0050908 (implicated_via_orthology) | |
| Disease | Ciliopathies | 3.36e-03 | 110 | 164 | 4 | C4277690 | |
| Disease | platelet component distribution width | DENND2A SH3TC2 ABCC5 CTDSP2 CKB TRANK1 GNG12 PLEKHG3 PDS5A MUSK CCDC40 | 3.43e-03 | 755 | 164 | 11 | EFO_0007984 |
| Disease | lower body strength measurement | 3.50e-03 | 16 | 164 | 2 | EFO_0007999 | |
| Disease | severe acute respiratory syndrome, COVID-19 | 3.66e-03 | 447 | 164 | 8 | EFO_0000694, MONDO_0100096 | |
| Disease | delta-5 desaturase measurement, response to polyunsaturated fatty acid supplementation | 3.95e-03 | 17 | 164 | 2 | EFO_0007764, EFO_0009131 | |
| Disease | plasma beta-amyloid 1-40 measurement | 3.95e-03 | 17 | 164 | 2 | EFO_0005659 | |
| Disease | Congenital Fiber Type Disproportion | 4.43e-03 | 18 | 164 | 2 | C0546264 | |
| Disease | Chronic myeloproliferative disorder | 4.93e-03 | 19 | 164 | 2 | C1292778 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RLLRKSIDAEVRELV | 621 | Q99569 | |
| TAKLLLSRENIREVI | 96 | Q9BYV9 | |
| SRKRESELLLFTERL | 581 | Q7Z3E2 | |
| ITIRRKAELAATLGL | 211 | Q99626 | |
| LAIIRERSSCVKILL | 156 | Q9H672 | |
| ELARVLRSVFVSERK | 456 | Q9H211 | |
| KIEEVRAILRTLLEA | 236 | Q8TAV3 | |
| SILRRETLNAKEIVV | 271 | Q9Y2F9 | |
| IEDAVHVLLKTRRIL | 646 | Q9P2G1 | |
| EILRLRERLLSASKE | 541 | Q9UDT6 | |
| ATLIIDILSEAKRRQ | 341 | Q9Y2X7 | |
| ESRILVLTELLERKA | 46 | Q9NWX5 | |
| LCSRLEKEAARIELV | 1061 | Q9P1Z9 | |
| ASLLLERRVIFVADK | 891 | P78524 | |
| ERRVIFVADKLSTLS | 896 | P78524 | |
| ARCLIRRKIVTLDSL | 11 | P52569 | |
| ELVLLREKSRALEAS | 381 | A6NI56 | |
| ITALIRREVKAAVSR | 981 | Q8IWY9 | |
| SLVVKLADTDRERAL | 206 | Q96J87 | |
| LVRLLRKTTDLEIRE | 641 | Q9UQB3 | |
| RELVLAVSKVEELTR | 226 | Q13625 | |
| ADLRLIEIKSTTLRV | 161 | Q93084 | |
| ETVLRRIKVTFLDTV | 161 | Q2TAZ0 | |
| EVGVIAKALVRLLRS | 336 | Q13367 | |
| AAEALTREFSVLKIR | 366 | Q9Y3T6 | |
| IVTIITAAKRDLALV | 381 | Q29RF7 | |
| AREVIEALLRKFLVV | 226 | Q9NS23 | |
| ASIERALLRECSVIK | 176 | Q2KHR3 | |
| KVLASLIIRLALAET | 1206 | Q92878 | |
| VREILTAQTLKIRAE | 106 | Q5JS13 | |
| GAKLLLEVSERVRTL | 531 | Q8IVL6 | |
| LRKSRILVLDEATAA | 1441 | O15438 | |
| IRARIFLIASKELEL | 656 | Q92542 | |
| RLRATAERVKALESA | 866 | P33176 | |
| VKTVRERLAIALIAD | 161 | Q8WWY6 | |
| AILLASRELVRSKRL | 781 | Q86T65 | |
| DARVKLVTELLSGIR | 456 | Q5T3U5 | |
| IFKDLSIRSVRLVRD | 61 | Q15056 | |
| LDAVTRGLKTALVER | 86 | P43304 | |
| TLVFEVELLKIERRT | 126 | P26885 | |
| IRVLSDVAKSRAIAI | 1546 | Q14643 | |
| LESVRILKSAEGRVL | 486 | P13196 | |
| RRAIEKLAVEALSSL | 151 | P12277 | |
| LIEAKFRVERIATLR | 761 | Q38SD2 | |
| RTRILELESSLEKSL | 566 | Q13439 | |
| LIADDTRVVVDLLKL | 3541 | O95714 | |
| TALVVAVVARKLELT | 386 | Q9H2S1 | |
| RLTRAVLRDLTDILK | 241 | Q8NAA5 | |
| AAVLEIVERLTKLIR | 106 | Q92485 | |
| LRRVLDELTLSKTDL | 211 | P13646 | |
| DSFVREIVARLLSKI | 4306 | Q5CZC0 | |
| LITSGRRILADEALK | 151 | Q08426 | |
| SRVVLRVLEAAVAAK | 131 | Q14232 | |
| KTRLALEAEVSELRA | 1241 | Q7Z406 | |
| RLTLLALLDRTEDIK | 826 | A6NKB5 | |
| LRVIRTAVEKLSRAE | 11 | Q6L8Q7 | |
| AVRAKVSRLVAAVVL | 256 | Q969F8 | |
| LTEVSRSEAVALLKR | 566 | Q8TBB1 | |
| DTDLVTKRILSARLL | 96 | Q86VQ0 | |
| ARDLIKLLARSVSFE | 116 | Q13601 | |
| RKLELEAAVTRLRAE | 76 | O94927 | |
| TRRAVTLRVLLKDAL | 71 | Q8N594 | |
| TLRLELDAGRVKLTV | 766 | Q9ULB1 | |
| VALLRRFKVSDEVLD | 256 | Q86VP3 | |
| SLRSLERKAIRAIED | 86 | Q14990 | |
| LRLLEVLISKRDTDS | 1006 | O94988 | |
| SRKRRLAELTVDEFL | 6 | Q9Y3T9 | |
| SLLIRRELTERAKDF | 161 | Q99623 | |
| LVRFLLKRAVSDLRV | 936 | O00750 | |
| SLSLVLRKTLDREEI | 191 | Q9Y5I0 | |
| RSGLLVLVIRAASKE | 6161 | Q5VST9 | |
| ASLEILRKELTRAVS | 221 | Q3B8N5 | |
| VRISDIGLADLRSKL | 1256 | O15440 | |
| ILAGVISDRLEKRAS | 381 | P57057 | |
| RETLLARLVDSIKDF | 441 | Q8NCM8 | |
| RVKELLTLIRSDAVA | 591 | Q15067 | |
| SARVTELGLAVKRLE | 396 | Q5TZA2 | |
| AVALIRKLIAVLESI | 961 | Q9ULT8 | |
| LRLAVKLDITAEILA | 151 | Q9NP55 | |
| EERASLSRDKRLALV | 801 | Q6AI39 | |
| KSLEIRTLAVERLLE | 16 | P35221 | |
| LRLEASIERIKVSKA | 21 | Q9UBI6 | |
| RSLKVFELDLVTLRS | 2196 | P49454 | |
| RRVIFIADKLSILSK | 766 | Q9ULE3 | |
| IITQARREDALVLTK | 6 | O14595 | |
| LLVAEKSRRQTILEL | 161 | Q4L180 | |
| SVTNLEDLKRRILRV | 501 | Q8NCG7 | |
| LRELSEELRVSKVFA | 391 | Q7L775 | |
| RLIELIRSAKEFIVL | 111 | Q5JV73 | |
| VARLELDAIELTRKL | 741 | Q5T1B0 | |
| DKRLALIATILDRVR | 1101 | Q4G0X9 | |
| ILEEDLRTARSALKL | 1376 | Q9BV73 | |
| LKSEILRLESRVLEL | 86 | A2IDD5 | |
| LLAAREDLSKIIRTS | 271 | Q52LJ0 | |
| ELIRSLRRAEAEKVS | 51 | Q96PX6 | |
| SERIALTNKIRVIFE | 1601 | Q0VDD8 | |
| AEAATKILTELRRLA | 596 | Q8IWC1 | |
| IVLCETFRKRLVLSV | 381 | Q99705 | |
| VTVLSRILARRLDEK | 201 | O75828 | |
| GAVVILRKDSASRLV | 336 | Q13683 | |
| VLEEKVLRLTRTVLD | 186 | Q9BXX0 | |
| TRLLRSKEAAAAVDI | 1106 | Q14689 | |
| LSLVKRIERTGIAAI | 166 | Q9NX74 | |
| LAKELVEVREALSRA | 141 | Q8IVE0 | |
| TALVFLDKRIVAARL | 1011 | Q12770 | |
| KREALVVVTENLRLS | 241 | Q96RY7 | |
| ERLTTLEAKVLLLEA | 141 | Q96A83 | |
| AASKTVRLVIGRVLE | 1856 | Q12923 | |
| ISRVEESALRALREK | 551 | O14830 | |
| KLRTDLRFIAELTIV | 261 | Q9HAU5 | |
| ILSLERLRQAVTVKE | 1356 | Q9H1H9 | |
| RRSVIEISRALKELF | 791 | Q9Y6R4 | |
| LSLQREKIIARVSID | 346 | Q9NP80 | |
| DTRSLEARIIALSVK | 121 | P82914 | |
| VDTIAKRRAELILER | 1191 | Q5TCS8 | |
| IRDIARSTLAKIIED | 1861 | O75691 | |
| STAVELVRLRSLEAK | 546 | O15034 | |
| IKSAAVAERERVSRL | 256 | Q96LD4 | |
| RIVERAEIKLRLDSI | 631 | P28370 | |
| LEFIRSTVLKDVLRT | 281 | Q3MII6 | |
| LVKTFTAAVRAELIR | 451 | Q6UX01 | |
| ESALSTRDRLLLDKI | 706 | A1L390 | |
| RASEVRKLILFLTDE | 521 | Q8IVG5 | |
| ETLEALILKELSVIR | 746 | O14802 | |
| IESISRKLQVLREAR | 1441 | Q13796 | |
| AVRTELRIFNKLTEL | 1121 | Q8TF17 | |
| DERVLSLKILSDRVA | 101 | Q99865 | |
| VLDSETLCRRAVKIL | 66 | Q15831 | |
| LRKIEAEIVRIACSL | 181 | O95470 | |
| LCREVLRLTKLVVDS | 546 | Q6P2Q9 | |
| LLFEIASARIEERKV | 76 | Q7Z614 | |
| AEILSLESRKELLVL | 351 | Q8ND24 | |
| LRSEAVERLSVLRTK | 306 | Q9BZV1 | |
| RLLSAILRVSEVESR | 606 | Q9C0E2 | |
| ERSLKLLFETRDISL | 2871 | O60673 | |
| VRLSQISEDVIRLFK | 126 | O43295 | |
| VSIFDISIARRKDLA | 656 | Q9H5L6 | |
| FIRLESRTLAEIAKA | 121 | Q8WXF1 | |
| RKLILFLETTLSERA | 241 | Q0VAA5 | |
| STREAELKLRLRLVE | 581 | Q5TF21 | |
| DERVLSLKILSDRVA | 101 | Q9BPZ2 | |
| LRLRVCVLSELQKTE | 21 | Q70Z35 | |
| RTLSKEILFRELEVR | 206 | Q9H9C1 | |
| LDTAIRVALAVAVLK | 186 | Q9UKJ0 | |
| LLVRTDKRSDSLIRV | 131 | Q9BQI6 | |
| IALAVLSTELAVRKL | 876 | P27708 | |
| KAEVLSFILEDVRAR | 601 | Q92797 | |
| IKRFEVLVIRLRDSL | 1986 | Q8IUG5 | |
| FAELISAIKRTLARL | 286 | Q96K49 | |
| VDSLSRLTKVEELRR | 16 | Q96T88 | |
| KDVAVVFSREELRLL | 26 | Q86WZ6 | |
| RDFQTELRKILVSLI | 146 | Q9BSL1 | |
| LLDRQSRSVVDVLKR | 276 | O15050 | |
| LVISIRVKELVSREL | 571 | Q5VYS8 | |
| FEIRSLRDSRALIEK | 666 | Q9P2L0 | |
| LSRVLFALSRLAVEK | 131 | Q9Y6I8 | |
| LEKVRIRDALRSILT | 696 | P56192 | |
| KLLEVTADLAERRRI | 16 | P53814 | |
| SELSLLEERFRVAIK | 96 | P52435 | |
| ISDLLSEAKLRLSRI | 91 | Q96A05 | |
| AVATRAGLLLDTIKR | 1106 | Q9P2D8 | |
| SIELLRRKIAQLIES | 661 | Q9C0D4 | |
| VADLTESILKNLRRV | 256 | Q6ZMR3 | |
| VRKEEVLILRSQLVS | 1261 | Q9Y4I1 | |
| VKDRVIDSRLQLFIT | 261 | O15146 | |
| SLEVVRAKRAGELLS | 3401 | P20929 |